| GSK Pays CureVac $328M in mRNA Vaccines Pact—Excluding COVID-19 | Frank Vinluan | 07/20/20 | Europe |
| Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More | Frank Vinluan | 12/13/19 | National |
| Bio Roundup: Biogen’s Reversal, FDA Moves Fast, a CF Cocktail & More | Sarah de Crescenzo | 10/25/19 | National |
| Bayer Buys Out BlueRock, Betting at Least $240M More on Cell Therapy Work | Ben Fidler | 08/08/19 | Boston |
| CRISPR Therapeutics Switches CEOs As It Approaches First Clinical Study | Alex Lash | 10/02/17 | Boston |
| How Bayer and Ginkgo Teamed Up in a $100M Synthetic Biology Bet | Frank Vinluan | 09/18/17 | Boston |
| Seeking to Join Editas, Intellia, CRISPR Tx Makes Long Awaited IPO Push | Ben Fidler | 09/12/16 | Boston |
